The agency cited quality issues at facilities testing Dexcom’s G6 and G7 monitors, including inadequate validation and risk ...

Dexcom made a significant design change to a component used in its sensors and did not adequately validate the change, ...

Eligible residents living with diabetes in Saskatchewan who rely on any type of insulin may be eligible to receive coverage ...

A company spokesperson said Dexcom plans to resolve the agency's concerns but stated no design changes were made to its ...

Dexcom previews new data for 15-day glucose monitor Dexcom shared the first data for its 15-day ... Tandem found that people ...

DexCom receives a warning letter from the FDA citing several issues with its popular G6 & G7 sensor manufacturing ... of its G7 Continuous Glucose Monitoring Systems with Nanowear's SimpleSense ...

Dexcom’s investigational 15-day continuous glucose monitor has a lower mean absolute relative difference than the current ...

AI-enhanced glucose monitoring provides predictive analytics and personalized insights for better blood sugar management.

Dexcom (Nadsaq:DXCM) today announced new insulin delivery integrations and updates on enhanced continuous glucose monitors ...

The U.S. FDA’s March 4, 2025, warning letter to Dexcom Inc. is a well-detailed but heavily redacted document explaining the agency’s misgivings about procedures such as monitoring of acetaminophen ...

If you have diabetes, a continuous glucose monitor (CGM ... including the Dexcom G7 or its earlier version, the Dexcom G6. What part of Medicare covers the Dexcom G7? Generally, Medicare Part ...